Back to top

Voyager Therapeutics presents six-month toxicology data for VY1706

Voyager Therapeutics (VYGR) presented six-month good laboratory practice toxicology data for VY1706, the company’s investigational gene therapy tar...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Voyager Therapeutics, Inc. (VYGR)